Table 2.
Response | RECIST 1.1 | Modified RECIST | ||||
---|---|---|---|---|---|---|
LENV Group | ATE/BEV Group | p-Value | LENV Group | ATE/BEV Group | p-Value | |
Complete response | 2 (1.4) | 3 (3.5) | 0.745 | 2 (1.4) | 3 (3.5) | 0.742 |
Partial response | 44 (30.1) | 25 (29.1) | 47 (32.2) | 27 (31.4) | ||
Stable disease | 66 (45.2) | 37 (43.0) | 63 (43.2) | 35 (40.7) | ||
Progressive disease | 34 (23.3) | 21 (24.4) | 34 (23.3) | 21 (24.4) | ||
Objective response rate | 31.5 | 32.6 | 0.868 | 33.6 | 34.9 | 0.485 |
Disease control rate | 76.7 | 75.6 | 0.760 | 76.8 | 75.6 | 0.682 |
Data are presented as n (%) or %, as appropriate. RECIST, Response Evaluation Criteria in Solid Tumors.